Steris (STE)
NYSE: STE · Health Care Equipment · Dublin, L2
Our rating: Neutral
Call changed from Positive to Neutral at $252.30, moderate conviction, November 6, 2026.
Breaks if: The Neutral call turns Cautious if revenue growth decelerates below 5% for two consecutive quarters — it is running at 8.7% now, so that would signal genuine franchise momentum loss — or if net margin falls below 11%, which at this multiple would be difficult to defend without sharp multiple compression. It turns Positive if free cash flow yield rises durably above 4.5% through margin expansion rather than a price pullback alone, or if revenue growth re-accelerates above 10% for two straight quarters, suggesting the business is running meaningfully ahead of current market expectations.
Key figures
| Market value | $24.8B |
|---|---|
| Revenue, last 12 months | $6.2B |
| Net income, last 12 months | $827M |
| Free cash flow, last 12 months | $937M |
| Price to earnings | 30.0× |
| Free cash flow yield | 3.8% |
| Dividend yield | 1.0% |
| Operating margin | 19.0% |
| Return on equity | 11.6% |
| Beta to the S&P 500 | 0.44 |
| Volatility, annualized | 24.1% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.6B | 8.8% | n/a | $213M |
| June 30, 2026 | $1.5B | 7.3% | n/a | $280M |
| March 31, 2026 | $1.6B | 7.3% | $2.24 | $245M |
| December 31, 2025 | $1.5B | 9.2% | $1.96 | $200M |
| September 30, 2025 | $1.5B | 9.9% | $1.94 | $201M |
| June 30, 2025 | $1.4B | 8.7% | $1.79 | $326M |
| March 31, 2025 | $1.5B | 4.3% | $1.47 | $190M |
| December 31, 2024 | $1.4B | 5.6% | $1.75 | $244M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.62B: Claude 72%, Gemini 85%, Mistral 60%
- Diluted earnings per share are at least $1.96: Claude 62%, Gemini 80%, Mistral 75%
- Free cash flow for the quarter is at least $0.20B: Claude 65%, Gemini 85%, Mistral 85%
- Backlog at the end of the quarter is at least $1.53B: Claude 45%, Gemini 55%, Mistral 55%
6 ledger entries and 27 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.